Prelude Capital Management, LLC Tg Therapeutics, Inc. Put Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $216,432 - $511,056
43,200 New
43,200 $511,000
Q1 2022

May 16, 2022
BUY
$7.81 - $20.45 $2,343 - $6,135
300 Added 0.7%
43,200 $411,000
Q4 2021

Feb 14, 2022
BUY
$15.2 - $35.51 $44,080 - $102,979
2,900 Added 7.25%
42,900 $815,000
Q3 2021

Nov 15, 2021
BUY
$21.78 - $40.45 $871,200 - $1.62 Million
40,000 New
40,000 $1.33 Million

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email